These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 17206734

  • 1. Combined mass spectrometry and dynamic chemistry approach to identify metalloenzyme inhibitors.
    Liénard BM, Selevsek N, Oldham NJ, Schofield CJ.
    ChemMedChem; 2007 Feb; 2(2):175-9. PubMed ID: 17206734
    [No Abstract] [Full Text] [Related]

  • 2. Complexes of thiomandelate and captopril mercaptocarboxylate inhibitors to metallo-beta-lactamase by polarizable molecular mechanics. Validation on model binding sites by quantum chemistry.
    Antony J, Piquemal JP, Gresh N.
    J Comput Chem; 2005 Aug; 26(11):1131-47. PubMed ID: 15937993
    [Abstract] [Full Text] [Related]

  • 3. Dynamic combinatorial mass spectrometry leads to metallo-beta-lactamase inhibitors.
    Liénard BM, Hüting R, Lassaux P, Galleni M, Frère JM, Schofield CJ.
    J Med Chem; 2008 Feb 14; 51(3):684-8. PubMed ID: 18205296
    [Abstract] [Full Text] [Related]

  • 4. Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester.
    Kurosaki H, Yamaguchi Y, Higashi T, Soga K, Matsueda S, Yumoto H, Misumi S, Yamagata Y, Arakawa Y, Goto M.
    Angew Chem Int Ed Engl; 2005 Jun 20; 44(25):3861-4. PubMed ID: 15892033
    [No Abstract] [Full Text] [Related]

  • 5. Thiols as classical and slow-binding inhibitors of IMP-1 and other binuclear metallo-beta-lactamases.
    Siemann S, Clarke AJ, Viswanatha T, Dmitrienko GI.
    Biochemistry; 2003 Feb 18; 42(6):1673-83. PubMed ID: 12578382
    [Abstract] [Full Text] [Related]

  • 6. Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases.
    Lassaux P, Hamel M, Gulea M, Delbrück H, Mercuri PS, Horsfall L, Dehareng D, Kupper M, Frère JM, Hoffmann K, Galleni M, Bebrone C.
    J Med Chem; 2010 Jul 08; 53(13):4862-76. PubMed ID: 20527888
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols.
    Liénard BM, Garau G, Horsfall L, Karsisiotis AI, Damblon C, Lassaux P, Papamicael C, Roberts GC, Galleni M, Dideberg O, Frère JM, Schofield CJ.
    Org Biomol Chem; 2008 Jul 07; 6(13):2282-94. PubMed ID: 18563261
    [Abstract] [Full Text] [Related]

  • 9. Inhibitors of metallo-beta-lactamase generated from beta-lactam antibiotics.
    Badarau A, Llinás A, Laws AP, Damblon C, Page MI.
    Biochemistry; 2005 Jun 21; 44(24):8578-89. PubMed ID: 15952764
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and evaluation of 3-(carboxymethylidene)- and 3-(carboxymethyl)penicillinates as inhibitors of beta-lactamase.
    Buynak JD, Ghadachanda VR, Vogeti L, Zhang H, Chen H.
    J Org Chem; 2005 May 27; 70(11):4510-3. PubMed ID: 15903334
    [Abstract] [Full Text] [Related]

  • 11. O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site.
    Wyrembak PN, Babaoglu K, Pelto RB, Shoichet BK, Pratt RF.
    J Am Chem Soc; 2007 Aug 08; 129(31):9548-9. PubMed ID: 17628063
    [No Abstract] [Full Text] [Related]

  • 12. Statistical prediction of protein chemical interactions based on chemical structure and mass spectrometry data.
    Nagamine N, Sakakibara Y.
    Bioinformatics; 2007 Aug 01; 23(15):2004-12. PubMed ID: 17510168
    [Abstract] [Full Text] [Related]

  • 13. PM3-compatible zinc parameters optimized for metalloenzyme active sites.
    Brothers EN, Suarez D, Deerfield DW, Merz KM.
    J Comput Chem; 2004 Nov 15; 25(14):1677-92. PubMed ID: 15362125
    [Abstract] [Full Text] [Related]

  • 14. Inhibitors of the FEZ-1 metallo-beta-lactamase.
    Liénard BM, Horsfall LE, Galleni M, Frère JM, Schofield CJ.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):964-8. PubMed ID: 17157014
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone.
    Kiviranta PH, Salo HS, Leppänen J, Rinne VM, Kyrylenko S, Kuusisto E, Suuronen T, Salminen A, Poso A, Lahtela-Kakkonen M, Wallén EA.
    Bioorg Med Chem; 2008 Sep 01; 16(17):8054-62. PubMed ID: 18701307
    [Abstract] [Full Text] [Related]

  • 19. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H, Bahn YJ, Ryu SE.
    Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4330-4. PubMed ID: 19497739
    [Abstract] [Full Text] [Related]

  • 20. Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1).
    Sun D, Wang Z, Di Y, Jaen JC, Labelle M, Ma J, Miao S, Sudom A, Tang L, Tomooka CS, Tu H, Ursu S, Walker N, Yan X, Ye Q, Powers JP.
    Bioorg Med Chem Lett; 2008 Jun 15; 18(12):3513-6. PubMed ID: 18511278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.